Patent · US Active

Compounds for treatment of pain

US10072018B2 · kind B2 · utility

0Cited by
1References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 16, 2014
Grant dateSep 11, 2018
Priority date
Expiry dateApr 16, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The aspects of the disclosed embodiments are directed to novel compounds, specifically, quaternary ammonium derivatives of tertiary amine containing opioid drug compounds such as hydrocodone, hydromorphone and oxycodone, formulations containing said. compounds or pharmaceutically acceptable salts thereof, which are capable of providing controlled release of the opioid drug upon administration to a patient in order to treat pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.